Propofol infusion syndrome
Open Access
- 20 February 2013
- journal article
- research article
- Published by Elsevier in Continuing Education in Anaesthesia Critical Care & Pain
- Vol. 13 (6) , 200-202
Abstract
The term PRIS—propofol infusion syndrome—was originally coined by Bray in 1998 to describe the adverse effects associated with the use of propofol in the paediatric population. PRIS was defined as acute refractory bradycardia leading to asystole in the presence of one or more of the following: metabolic acidosis (base excess of −10 mmol litre−1), rhabdomyolysis or myoglobinuria, lipaemic plasma, or enlarged liver or fatty liver.1Keywords
This publication has 7 references indexed in Scilit:
- Propofol Infusion SyndromeAmerican Journal of Therapeutics, 2010
- Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter studyCritical Care, 2009
- Propofol Infusion SyndromeDrug Safety, 2008
- Propofol infusion syndromeAnaesthesia, 2007
- The pathophysiology of propofol infusion syndrome: a simple name for a complex syndromeIntensive Care Medicine, 2003
- Long-term propofol infusion and cardiac failure in adult head-injured patientsThe Lancet, 2001
- Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports.BMJ, 1992